研究报告 |
|
|
|
|
mpt64-卡介苗重组疫苗的构建、免疫原性及抗结核作用 |
孙颖1,2, 张灵霞3, 吴雪琼3, 董恩军3 |
1. 中国科学院北京基因组研究所 北京 101300;
2. 北京技术交易促进中心 北京 100080;
3. 中国人民解放军第309医院结核病研究所 北京 100091 |
|
The Study On Construction, Immunogenicity and Protection Against Mycobacterium tuberculosis ofmpt64-recombinant BCG Vaccine |
SUN Ying1,2, ZHANG Ling-xia3, WU Xue-qiong3, DONG En-jun3 |
1. Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 101300, China;
2. Beijing Technology Exchange & Promotion Center, Beijing 100080, China;
3. The 309th Hospital of PLA, Beijing 100091, China |
引用本文:
孙颖, 张灵霞, 吴雪琼, 董恩军. mpt64-卡介苗重组疫苗的构建、免疫原性及抗结核作用[J]. 中国生物工程杂志, 2011, 31(7): 14-19.
SUN Ying, ZHANG Ling-xia, WU Xue-qiong, DONG En-jun. The Study On Construction, Immunogenicity and Protection Against Mycobacterium tuberculosis ofmpt64-recombinant BCG Vaccine. China Biotechnology, 2011, 31(7): 14-19.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/
或
https://manu60.magtech.com.cn/biotech/CN/Y2011/V31/I7/14
|
[1] 张灵霞, 吴雪琼, 史迎昌,等. 几种结核分支杆菌重组蛋白诱发豚鼠迟发型超敏反应的研究. 中国防痨杂志,2002, 24(4):35-37. Zhang L X, Wu X Q, Shi Y C, et al. Chin J Antitub, 2002, 24(4):35-37.
[2] Sambrook J, Fristsch E F, Maniatist. 分子克隆实验指南. 第2版. 北京:科学出版社,1959.19-59. Sambrook J, Fristsch E F, Maniatist. Protocols in Molecular Clone. 2nd ed. Beijing: Science Press, 1959. 19-59.
[3] 熊志红, 庄玉辉. 结核分枝杆菌mpt64基因的克隆及其在大肠杆菌种的表达、纯化和诊断运用. 中国现代医学杂志, 2004, 14(21):48-51. Xiong Z H, Zhuang Y H. China J Modern Medicine, 2004, 14(21):48-51.
[4] 张灵霞, 吴雪琼, 李洪敏,等. 结核分枝杆菌重组MPT64蛋白对豚鼠淋巴细胞增殖反应的影响.中国防痨杂志, 2004, 26(4):248-249. Zhang L X, Wu X Q, Li H M, et al. Chin J Antitub, 2004, 26(4):248-249.
[5] 路艳艳, 冯作化, 皇铺永穆,等. 新型大肠杆菌-分枝杆菌穿梭载体的构建及卡那酶素抗性基因表达的研究. 同济医科大学学报, 1998, 27(2):89-93. Lu Y Y, Feng Z H, Huangpu Y M, et al. J Tongji Medical University, 1998, 27(2):89-93.
[6] 路艳艳, 皇铺永穆. 电穿孔法对分枝杆菌进行高效基因转化. 北京医科大学学报, 2000, 32(2):178-181. Lu Y Y, Huangpu Y M. J Peking University (Health Sciences), 2000, 32(2):178-181.
[7] Winter N, Lagranderie M, Gangloff S, et al. Recombinant BCG strains expressing the SIVmac251nef gene induce proliferative and CTL responses against nef synthetic peptides in mice. Vaccine, 1995,13(5):471-478.
[8] Bao L, Chen W, Zhang H D, et al. Virulence, Immunogenicity, and Protective Efficacy of Two Recombinant Mycobacterium bovis Bacillus Calmette-Guérin Strains Expressing the Antigen ESAT-6 from Mycobacterium tuberculosis. Infection and Immunity, 2003, 71(4):1656-1661.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|